Microbot Medical Files 8-K
Ticker: MBOT · Form: 8-K · Filed: Apr 29, 2024 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Apr 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
Microbot Medical filed an 8-K on 4/29/24 for Reg FD and financials.
AI Summary
Microbot Medical Inc. filed an 8-K on April 29, 2024, reporting on Regulation FD disclosures and financial statements. The company, formerly known as Cytotherapeutics Inc./DE and Stemcell Inc., is incorporated in Delaware and headquartered in Braintree, MA.
Why It Matters
This filing provides an update on Microbot Medical's regulatory and financial disclosures, which are important for investors to understand the company's current status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K for disclosures and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- Cytotherapeutics Inc./DE (company) — Former company name
- Stemcell Inc. (company) — Former company name
- April 29, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Regulation FD disclosures and to provide financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on April 29, 2024.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is MICROBOT MEDICAL INC.
In which state is Microbot Medical Inc. incorporated?
Microbot Medical Inc. is incorporated in Delaware.
What are the former names of Microbot Medical Inc. mentioned in the filing?
The filing mentions two former names for Microbot Medical Inc.: STEMCELLS INC and CYTOTHERAPEUTICS INC/DE.
Filing Stats: 629 words · 3 min read · ~2 pages · Grade level 11.8 · Accepted 2024-04-29 08:30:20
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 11KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-24-016854.txt ( ) — 230KB
- mbot-20240429.xsd (EX-101.SCH) — 3KB
- mbot-20240429_lab.xml (EX-101.LAB) — 33KB
- mbot-20240429_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: April 29, 2024